Roche Diagnostics Amplicor, Cobas HCV RNA Tests To Launch By October
This article was originally published in The Gray Sheet
Roche Diagnostics' Amplicor Version 2.0 and Cobas Amplicor automated Version 2.0 hepatitis C (HCV) qualitative RNA tests are expected to launch Sept. 28. The firm announced FDA approval of the tests July 9.
You may also be interested in...
Roche Molecular Systems should include in labeling for the Amplicor Version 2.0 and Cobas Amplicor automated Version 2.0 hepatitis C tests a warning that heparin use could lead to an "HCV not-detected" result, FDA's Microbiology Devices Panel agreed in recommending FDA approval at a July 28 meeting.
"We're particularly concerned about the health care area right now because obviously that's driving everything now," says Tennessee AG Herbert Slatery III. He and CRN CEO Steve Mister spoke with HBW Insight about regulation of the consumer health marketplace with FDA suspending inspections of facilities operated by businesses manufacturing and marketing products subject to its oversight.
In addition to our daily in-depth coverage of key events relating to the coronavirus pandemic, we’re bringing you a periodic round-up of other significant developments.